Cargando…

Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions

Detalles Bibliográficos
Autores principales:	Kopper, Timothy J., Gensel, John C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996014/ https://www.ncbi.nlm.nih.gov/pubmed/32985477 http://dx.doi.org/10.4103/1673-5374.293146

Ejemplares similares

Delayed Azithromycin Treatment Improves Recovery After Mouse Spinal Cord Injury
por: Kopper, Timothy J., et al.
Publicado: (2019)

Therapeutic implications of advanced age at time of spinal cord injury
por: Stewart, Andrew N., et al.
Publicado: (2019)

Azithromycin drives alternative macrophage activation and improves recovery and tissue sparing in contusion spinal cord injury
por: Zhang, Bei, et al.
Publicado: (2015)

Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment
por: Gensel, John C., et al.
Publicado: (2017)

Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injury
por: Rabchevsky, Alexander G., et al.
Publicado: (2017)

Interactions of primary insult biomechanics and secondary cascades in spinal cord injury: implications for therapy
por: Orr, Michael B., et al.
Publicado: (2017)

Data and subject heterogeneity and data sharing: keys to translational success in spinal cord injury research?
por: Fouad, Karim, et al.
Publicado: (2022)

Immunomodulation as a neuroprotective strategy after spinal cord injury
por: Monteiro, Susana, et al.
Publicado: (2018)

Potential therapeutic mechanism of traditional Chinese medicine monomers on neurological recovery after spinal cord injury
por: Zhang, Tao, et al.
Publicado: (2021)

Sexual Dimorphism of Pain Control: Analgesic Effects of Pioglitazone and Azithromycin in Chronic Spinal Cord Injury
por: Gensel, John C., et al.
Publicado: (2019)

Modification of autophagy-lysosomal pathway as a neuroprotective treatment for spinal cord injury
por: Lipinski, Marta M., et al.
Publicado: (2015)

Spinal cord injury: potential neuroprotective therapy based on neural-derived peptides
por: García, Elisa, et al.
Publicado: (2016)

The effects of myelin on macrophage activation are phenotypic specific via cPLA(2) in the context of spinal cord injury inflammation
por: Kopper, Timothy J., et al.
Publicado: (2021)

Topiramate Treatment Is Neuroprotective and Reduces Oligodendrocyte Loss after Cervical Spinal Cord Injury
por: Gensel, John C., et al.
Publicado: (2012)

Exosomes in neurological disease, neuroprotection, repair and therapeutics: problems and perspectives
por: Kalani, Anuradha, et al.
Publicado: (2015)

Priorities in reducing child mortality: Azithromycin and other interventions
por: Mabey, David, et al.
Publicado: (2020)

Therapeutic exploitation of the S-nitrosoglutathione/S-nitrosylation mechanism for the treatment of contusion spinal cord injury
por: Khan, Mushfiquddin, et al.
Publicado: (2019)

Repositioning imatinib for spinal cord injury
por: Kjell, Jacob, et al.
Publicado: (2015)

Fertility treatment in spinal cord injury and other neurologic disease
por: Trofimenko, Vera, et al.
Publicado: (2016)

Neuromodulator interactions and spinal cord injury in lamprey
por: Parker, David, et al.
Publicado: (2018)

Spinal cord injury: can we repair spinal cord non-invasively by using magnetic stimulation?
por: Delarue, Quentin, et al.
Publicado: (2021)

MicroRNA-based targeting of the Rho/ROCK pathway in therapeutic strategies after spinal cord injury
por: Kimura, Tetsu, et al.
Publicado: (2022)

Current stem cell treatments for spinal cord injury
por: Vawda, R, et al.
Publicado: (2012)

Technical comments on rodent spinal cord injuries models
por: Zhang, Zoe, et al.
Publicado: (2014)

Micromechanical adaptation as a treatment for spinal cord injury
por: Estrada, Veronica, et al.
Publicado: (2019)

Rethinking the Body in the Brain after Spinal Cord Injury
por: Leemhuis, Erik, et al.
Publicado: (2022)

In vivo astrocyte reprogramming following spinal cord injury
por: Gerber, Yannick N., et al.
Publicado: (2023)

Reorganization of spinal neural circuitry and functional recovery after spinal cord injury
por: Nardone, Raffaele, et al.
Publicado: (2015)

A Therapeutic Matrix: Virtual Reality as a Clinical Tool for Spinal Cord Injury-Induced Neuropathic Pain
por: Leemhuis, Erik, et al.
Publicado: (2021)

Enhanced motor cortex excitability after spinal cord injury
por: Raffaele, Nardone
Publicado: (2015)

Combinatorial therapies for spinal cord injury: strategies to induce regeneration
por: Gomes, Eduardo D., et al.
Publicado: (2019)

Disconnected Body Representation: Neuroplasticity Following Spinal Cord Injury
por: Leemhuis, Erik, et al.
Publicado: (2019)

Transneuronal delivery of designer cytokines: perspectives for spinal cord injury
por: Terheyden-Keighley, Daniel, et al.
Publicado: (2021)

Extracellular vesicles for neural regeneration after spinal cord injury
por: Lim, Young-Ju, et al.
Publicado: (2023)

Immunomodulatory Effects of Azithromycin Revisited: Potential Applications to COVID-19
por: Venditto, Vincent J., et al.
Publicado: (2021)

Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic neuroprotection after traumatic brain injury
por: Xiong, Ye, et al.
Publicado: (2018)

Neuroprotection by diarylpropionitrile in mice with spinal cord injury
por: Suwanna, Nirut, et al.
Publicado: (2014)

Neuroprotective role of Noggin in spinal cord injury
por: Al-Sammarraie, Nadia, et al.
Publicado: (2022)

Ligaments disruption: a new perspective in the prognosis of spinal cord injury
por: Martinez-Perez, Rafael, et al.
Publicado: (2014)

Neural prostheses for restoring functions lost after spinal cord injury
por: Fakhoury, Marc
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1t0oseo3if3u3nohvl1e6cp6ur